In the latest trading session,, 0.98 million Opko Health Inc (NASDAQ:OPK) shares changed hands as the company’s beta touched 1.80. With the company’s most recent per share price at $1.00 changed hands at -$0.01 or -0.50% at last look, the market valuation stands at $700.47M. OPK’s current price is a discount, trading about -124.0% off its 52-week high of $2.24. The share price had its 52-week low at $0.85, which suggests the last value was 15.0% up since then. When we look at Opko Health Inc’s average trading volume, we note the 10-day average is 15.06 million shares, with the 3-month average coming to 14.48 million.
Opko Health Inc (NASDAQ:OPK) trade information
Instantly OPK was in red as seen in intraday trades today. With action 15.48%, the performance over the past five days has been green. The drop to weekly highs of 1.0100 subtracted -0.50% to the stock’s daily price. The company’s shares are showing year-to-date downside of -33.44%, with the 5-day performance at 15.48% in the green. However, in the 30-day time frame, Opko Health Inc (NASDAQ:OPK) is 0.85% up. Looking at the short shares, we see there were 99.06 million shares sold at short interest cover period of 13.05 days.
Opko Health Inc (OPK) estimates and forecasts
Data shows that the Opko Health Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -37.19% over the past 6 months, a -32.00% in annual growth rate that is considerably lower than the industry average of 14.10%. Moreover, analysts have looked to lower expectations by upgrading its fiscal year 2024 revenue estimates. The rating firms predict current quarter revenue for Opko Health Inc will fall -350.00%, while the growth in revenue is estimated to hit -200.00% for the next quarter. Year-over-year growth is forecast to reach -10.50% down from the last financial year.
Consensus estimates given by 6 financial analysts project the company’s revenue in the current quarter to hit an average of $183.32 million. 6 analysts are of the opinion that Opko Health Inc’s revenue for the quarter ending Jun 2024 will be $191.12 million. The company’s revenue for the corresponding quarters a year ago was $237.6 million and $201.97 million respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -22.80%. The estimates for the next quarter sales put growth at -5.40%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 1.56%. The 2024 estimates are for Opko Health Inc earnings to decrease by -45.33%, but the outlook for the next 5-year period is at 12.00% per year.
OPK Dividends
Opko Health Inc is expected to release its next quarterly earnings report between May 01 and May 06.
Opko Health Inc (NASDAQ:OPK)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 52.42% of Opko Health Inc shares while 25.16% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 52.88%. There are 25.16% institutions holding the Opko Health Inc stock share, with Vanguard Group Inc the top institutional holder. As of Dec 30, 2023, the company held 5.70% of the shares, roughly 39.75 million OPK shares worth $40.15 million.
Blackrock Inc. holds the second largest percentage of outstanding shares, with 5.30% or 36.97 million shares worth $37.34 million as of Dec 30, 2023.
Among Mutual Funds, the top two as of Dec 30, 2023 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. With 12.73 million shares estimated at $12.86 million under it, the former controlled 1.83% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 1.44% of the shares, roughly 10.07 million shares worth around $10.17 million.
